Genfit

GNFT NASDAQ Healthcare & Biotech France
6.27 $
1.29 %

Genfit is a French biopharmaceutical company specializing in research and development of therapies for metabolic and inflammatory diseases, notably non-alcoholic steatohepatitis (NASH).

metabolic diseases NASH innovative therapies diagnostics